These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5250186)

  • 1. Busulphan and bone marrow depression.
    Weatherall DJ; Galton DA; Kay HE
    Br Med J; 1969 Mar; 1(5644):638. PubMed ID: 5250186
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of chronic myelocytic leukemia.
    Galton DA
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed toxic effect of busulfan on the marrow.
    Ganda OP; Mangalik A
    J Assoc Physicians India; 1973 Jun; 21(6):511-6. PubMed ID: 4525264
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan.
    Vicariot M; Goldman JM; Catovsky D; Galton DA
    Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Bone marrow damage during treatment of psoriasis with busulphan.
    Möller H; Waldenström J
    Acta Derm Venereol; 1973; 53(6):515-6. PubMed ID: 4129606
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple antibody response following busulfan therapy.
    Spitler L; Fudenberg HH
    Vox Sang; 1970 May; 18(5):450-8. PubMed ID: 4195319
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 9. Jaundice after treatment of leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic myeloid leukaemia and a myasthenic syndrome.
    Wohl MA; Wood JK
    Acta Haematol; 1979; 62(4):214-8. PubMed ID: 119414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E; Schwanitz G; Hartwich G
    Dtsch Med Wochenschr; 1974 Jan; 99(2):52-56. PubMed ID: 4520646
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholestatic jaundice following treatment of chronic granulocytic leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    J Clin Pathol; 1970 Dec; 23(9):827. PubMed ID: 5278972
    [No Abstract]   [Full Text] [Related]  

  • 13. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 14. Busulphan lung.
    Littler WA; Kay JM; Hasleton PS; Heath D
    Thorax; 1969 Nov; 24(6):639-55. PubMed ID: 5260190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Busulphan lung in childhood.
    Oakhill A; Green ID; Knowlson GT; Cameron AH; Shah KJ; Hill FG; Mann JR
    J Clin Pathol; 1981 May; 34(5):495-500. PubMed ID: 6941971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigmentation and busulphan therapy.
    Sprunt JG; Rizza CR
    Br Med J; 1966 Mar; 1(5489):736-7. PubMed ID: 5218233
    [No Abstract]   [Full Text] [Related]  

  • 17. Convulsions due to high-dose busulphan.
    Marcus RE; Goldman JM
    Lancet; 1984 Dec; 2(8417-8418):1463. PubMed ID: 6151067
    [No Abstract]   [Full Text] [Related]  

  • 18. Cataract after busulphan therapy.
    Akman N; Avanoğlu Y; Soysal T
    Acta Haematol; 1986; 76(4):236. PubMed ID: 3107313
    [No Abstract]   [Full Text] [Related]  

  • 19. Cataract after busulphan treatment.
    Ravindranathan MP; Paul VJ; Kuriakose ET
    Br Med J; 1972 Jan; 1(5794):218-9. PubMed ID: 4500985
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic myelocytic leukemia: apparent "recovery" for over nine years, following therapeutic medullary hypoplasia. A clinical and cytogenetic study].
    Mauruce PA; Ferrier S; Alberto P; Freund M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1781-2. PubMed ID: 5291101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.